Publications of F. Broecker
49 (64), pp. 7159 - 7161 (2013)Glycan arrays containing synthetic Clostridium difficile lipoteichoic acid oligomers as tools toward a carbohydrate vaccine. Chemical Communications
135 (26), pp. 9713 - 9722 (2013)Immunological evaluation of a synthetic Clostridium difficile oligosaccharide conjugate vaccine candidate and identification of a minimal epitope. Journal of the American Chemical Society
9, 134 (2012)Short hairpin-looped oligodeoxynucleotides reduce hepatitis C virus replication. Virology Journal
1518, pp. 227 - 240. Springer, New York (2017)Synthetic glycan microarrays. In: Methods in Molecular Biology, Vol.
Lepenies, B.). Springer Science+Business Media, New York (2015)Generation of monoclonal antibodies against defined oligosaccharide antigens. In: Carbohydrate-Based Vaccines, pp. 57 - 80 (Ed.
25 (5) Supplement 1 Ed., 728, p. 335 - 335. 20th Annual Meeting of the American Society of Gene and Cell Therapy, Washington, DC, May 10, 2017 - May 13, 2017. No longer published by Elsevier, San Diego, CA (2017)Analysis of the AAVrh. 10 capsid structure and its antigenic and receptor interactions. In Molecular Therapy,
24 (11), p. 1129 - 1129. Joint Meeting of the Society-for-Glycobiology (SFG) and the Japanese-Society-of-Carbohydrate-Research (JSCR), Honolulu, HI, November 16, 2014 - November 19, 2014. Oxford University Press, Oxford (2014)Deciphering glycan-antibody interactions: towards a carbohydrate-based vaccine against Clostridium difficile. In Glycobiology,
Thesis - PhD
Towards vaccines and therapeutic antibodies against Clostridium difficile based on synthetic glycans. Dissertation, 155 pp., Freie Universität Berlin, Berlin (2016)
Antibodies for prevention and treatment of diseases caused by Clostridium difficile. (2016)
Oligosaccharides and oligosaccharides-protein conjugates derived from clostridium difficile polysaccharide PS-I, methods of synthesis and uses thereof, in particular as vaccines and diagnostic tools. EP2739636 (2013)